- Home
- Publications
- Publication Search
- Publication Details
Title
REToma: a cancer subtype with a shared driver oncogene
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-11-07
DOI
10.1093/carcin/bgz184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancers.
- (2019) Matthew H. Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- First experience of LOXO-292 in the management of pediatric patients with RET-altered cancers.
- (2019) Ulrike Gerdemann et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of cell-free DNA from 32,989 advanced cancers reveals novel co-occurring activating RET alterations and oncogenic signaling pathway aberrations
- (2019) Thereasa A Rich et al. CLINICAL CANCER RESEARCH
- Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain
- (2019) Janna M. Bigalke et al. Science Advances
- Selective RET kinase inhibition for patients with RET-altered cancers
- (2018) V Subbiah et al. ANNALS OF ONCOLOGY
- Systematic Functional Annotation of Somatic Mutations in Cancer
- (2018) Patrick Kwok-Shing Ng et al. CANCER CELL
- Implementation of “clinical sequencing” in cancer genome medicine in Japan
- (2018) Takashi Kohno CANCER SCIENCE
- Pathogenic Germline Variants in 10,389 Adult Cancers
- (2018) Kuan-lin Huang et al. CELL
- Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene
- (2018) Duarte Mendes Oliveira et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients with RET -Rearranged Lung Cancers
- (2018) Alexander Drilon et al. Journal of Thoracic Oncology
- Clinical and Translational Implications of RET Rearrangements in Non–Small Cell Lung Cancer
- (2018) Roberto Ferrara et al. Journal of Thoracic Oncology
- Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers
- (2018) Robert Roskoski et al. PHARMACOLOGICAL RESEARCH
- A secondary RET mutation in the activation loop conferring resistance to vandetanib
- (2018) Takashi Nakaoku et al. Nature Communications
- Precision Targeted Therapy with BLU-667 for RET -Driven Cancers
- (2018) Vivek Subbiah et al. Cancer Discovery
- RET fusions observed in lung and colorectal cancers are sensitive to ponatinib
- (2018) Joseph M. Gozgit et al. Oncotarget
- Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions
- (2018) Alena Skálová et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with RET-altered cancers.
- (2018) Alexander E. Drilon et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- RET rearrangements are actionable alterations in breast cancer
- (2018) Bhavna S. Paratala et al. Nature Communications
- A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
- (2018) Alexander Drilon et al. Cancer Discovery
- Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- (2017) Oliver Gautschi et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
- (2017) Alexander Drilon et al. Nature Reviews Clinical Oncology
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- (2017) Cancer Discovery
- KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub
- (2017) Tirtha Kamal Das et al. Cell Reports
- Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
- (2017) Kiyotaka Yoh et al. Lancet Respiratory Medicine
- RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
- (2016) Shumei Kato et al. CLINICAL CANCER RESEARCH
- Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma
- (2016) Q. Huang et al. MOLECULAR CANCER THERAPEUTICS
- A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
- (2016) Cristina Romei et al. Nature Reviews Endocrinology
- Development of Lung Adenocarcinomas with Exclusive Dependence on Oncogene Fusions
- (2015) Motonobu Saito et al. CANCER RESEARCH
- Identification and characterization of RET fusions in advanced colorectal cancer
- (2015) Anne-France Le Rolle et al. Oncotarget
- RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
- (2014) K Tsuta et al. BRITISH JOURNAL OF CANCER
- A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis
- (2014) Motonobu Saito et al. CARCINOGENESIS
- Molecular Mechanisms Underlying Oncogenic RET Fusion in Lung Adenocarcinoma
- (2014) Tatsuji Mizukami et al. Journal of Thoracic Oncology
- Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans
- (2014) Iván Plaza-Menacho et al. MOLECULAR CELL
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- (2014) Thomas Wiesner et al. Nature Communications
- RET Recognition of GDNF-GFRα1 Ligand by a Composite Binding Site Promotes Membrane-Proximal Self-Association
- (2014) Kerry M. Goodman et al. Cell Reports
- Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies
- (2013) Daniela Bossi et al. Molecular Oncology
- Multiple Endocrine Neoplasia Type 2A Due to an Exon 8 (G533C) Mutation in a Large North American Kindred
- (2013) M. Regina Castro et al. THYROID
- RETFusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
- (2012) Rui Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation
- (2012) P Ballerini et al. LEUKEMIA
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- ALKoma: A Cancer Subtype with a Shared Target
- (2012) Hiroyuki Mano Cancer Discovery
- Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-Oncogene
- (2011) David K. Crockett et al. PLoS One
- Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro
- (2010) Marina Muzza et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now